Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06496568 |
Title | A Study Evaluating Single-agent Inavolisib and Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama at Birmingham Comprehensive Cancer Center | WITHDRAWN | Birmingham | Alabama | 35249 | United States | Details |
Moores Cancer Center at UC San Diego Health | RECRUITING | La Jolla | California | 92093 | United States | Details |
California Cancer Associates for Research & Excellence, Inc. | RECRUITING | San Marcos | California | 92069 | United States | Details |
Vanderbilt-Ingram Cancer Ctr | RECRUITING | Nashville | Tennessee | 37232 | United States | Details |
BC Cancer Vancouver Centre | RECRUITING | Vancouver | British Columbia | V5Z 4E6 | Canada | Details |
Princess Margaret Cancer Center | RECRUITING | Toronto | Ontario | M5G 2M9 | Canada | Details |
Jewish General Hospital | RECRUITING | Montreal | Quebec | H3T 1E2 | Canada | Details |
Seoul National University Hospital | ACTIVE_NOT_RECRUITING | Seoul | 03080 | Korea, Republic of | Details | |
Samsung Medical Center | RECRUITING | Seoul | 06351 | Korea, Republic of | Details |